Ćojbašić, Irena

Type

Date issued

85 2000 - 2027

Mp-cat.

65 М30/М60
5 M22
5 M23
3 M20/M50
3 M52
1 M21
1 M24
1 M51
1 M70

Date issued - custom

Year from:

Year to:

Results 21-40 of 85 Results/Page

Issue Date	Title	Author(s)	Type	Мp-cat.
2018	The effect of curcumin and PI3K/Akt inhibitor on monosodium lutamate-induced rat thymocytes toxicity	Vucic, Miodrag ; Ćojbašić, Irena ; Vucic, Jelena ; Pavlović, Voja	Article	23M23
2018	MACHINE LEARNING LEUKEMIA CLINICAL OUTCOME PREDICTION	Ćojbašić, Žarko M. ; Ćojbašić, Irena V. ; Nemanja Marković; Miroslav Trajanović	Conference Paper	Mp. category will be shown later
2018	The impact of smoking on presentation and clinical outcome of chronic myeloid leukemia	Ćojbašić, Irena V.	Conference Paper	Mp. category will be shown later
2018	Real-word data from long follow-up of imatinib initially treated chronic myeloid leukemia patients	Ćojbašić, Irena V. ; Mačukanović-Golubović L.,; Tijanić I.,	Conference Paper	Mp. category will be shown later
2018	Klinički tok bolesnika sa Gošeovom bolešću	Ćojbašić, Irena V.	Conference Paper	Mp. category will be shown later
2018	Machine learning in clinical outcome prediction for personalized medicine	Ćojbašić, Žarko M. ; Bojko Bjelaković ; Stevo Lukić ; Ćojbašić, Irena V.	Conference Paper	Mp. category will be shown later
2018	Comorbidity index related outcome in chronic myeloid leukemia patients	Ćojbašić, Irena V. ; Mačukanović-Golubović L.,; Vučić M.,	Conference Paper	Mp. category will be shown later
2017	The influence of age on treatment outcome of patients with chronic myeloid leukemia receiving frontline imatinib	Ćojbašić, Irena V. ; Mačukanović Golubović, Lana Đ. ; Vučić, Miodrag D. ; Govedarović, Nenad N.	Conference Paper	Mp. category will be shown later
2017	Delotvornost Helicobacter pylori eradikacije u porastu broja trombocita kod pacijenta sa idiopatskom trombocitopenijskom purpurom	Ćojbašić, Irena V.	Conference Paper	Mp. category will be shown later
2017	Analyses of Treatment Outcome According to Age in Patients With Chronic Myeloid Leukemia Receiving Front-line Imatinib Therapy	Ćojbašić, Irena ; Mačukanović Golubović, Lana ; Vučić, Miodrag ; Tijanić, Ivan	Article	22M22
2017	Značaj redovnog molekularnog praćenja pacijenata sa hroničnom mijeloidnom leukemijom tokom terapije inhibitorima tirozin kinaze - prikaz slučaja	Ćojbašić, Irena V.	Conference Paper	Mp. category will be shown later
2017	The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients	Ćojbašić, Irena ; Mačukanović Golubović, Lana ; Mihailović, Dragan ; Vučić, Miodrag ; Ćojbašić, Žarko	Article	22M22
2017	Ishod lečenja hronične mijeloidne leukemije sa generičkim imatinibom u prvoj liniji prema European LeukemiaNet 2013 baziranom Nacionalnom vodiču	Ćojbašić, Irena V. ; Mačukanović Golubović, Lana Đ. ; Vučić, Miodrag D. ; Tijanić, Ivan R.	Conference Paper	Mp. category will be shown later
2017	Iskustvo jednog centra o kliničkom ishodu mladih pacijenata sa hroničnom mijeloidnom leukemijom lečenih inhibitorima tirozin kinaze	Ćojbašić, Irena V. ; Mačukanović Golubović, Lana Đ. ; Vučić, Miodrag D. ; Govedarović, Nenad N.	Conference Paper	Mp. category will be shown later
2017	Analysis of generic imatinib efficacy in chronic myeloid leukemia treatment: more than four years of experience in Southern Serbia	Ćojbašić, Irena V. ; Mačukanović Golubović, Lana Đ. ; Vučić, Miodrag D. ; Tijanić, Ivan R.	Conference Paper	Mp. category will be shown later
2017	Computationally intelligent prediction of clinical outcome in chronic myeloid leukemia	Ćojbašić, Žarko M. ; Ćojbašić, Irena V. ; Mačukanović Golubović, Lana Đ. ; Vučić, Miodrag D.	Conference Paper	Mp. category will be shown later
2016	Evaluation of clinical efficacy and safety of generic imatinib in the treatment of chronic myeloid leukemia	Ćojbašić, Irena ; Mačukanović Golubović, Lana ; Vučić, Miodrag ; Govedarović, Nenad	Conference Paper	Mp. category will be shown later
2016	Comparison of treatment outcome among patients with chronic myeloid leukemia who achieved complete cytogenetic response within or after one year of imatinib mesylate therapy	Ćojbašić, Irena ; Mačukanović Golubović, Lana ; Vučić, Miodrag	Article	51M51
2016	Postizanje ranog i dubokog citogenetskog odgovora na imatinib predviđa dugoročni ishod kod pacijenata sa hroničnom mijeloidnom leukemijom	Ćojbašić, Irena ; Mačukanović Golubović, Lana ; Vučić, Miodrag ; Govedarović, Nenad ; Nikolić V	Conference Paper	Mp. category will be shown later
2016	Značaj prognostičkih skoring sistema kod pacijenata sa hroničnom mijeloidnom leukemijom koji su lečeni inhibitorima tirozin kinaze druge generacije	Ćojbašić, Irena ; Mačukanović Golubović, Lana ; Vučić, Miodrag ; Govedarović, Nenad ; Tijanić, Ivan	Conference Paper	Mp. category will be shown later